Publicaciones en las que colabora con Alberto Ortiz Arduan (24)

2024

  1. Consensus on the approach to hydrosaline overload in acute heart failure. SEMI/SEC/S.E.N. recommendations

    Revista Espanola de Cardiologia, Vol. 77, Núm. 7, pp. 556-565

  2. Gender-specific risk factors and outcomes of hyperkalemia in CKD patients: smoking as a driver of hyperkalemia in men

    Clinical Kidney Journal, Vol. 17, Núm. 1

  3. Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease

    Clinical Kidney Journal, Vol. 17, Núm. 3

2023

  1. Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 1, pp. 10-25

  2. SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 11, pp. 2444-2455

2021

  1. Correction to: Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies (Drugs, (2021), 81, 13, (1467-1489), 10.1007/s40265-021-01555-5)

    Drugs

  2. Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies

    Drugs, Vol. 81, Núm. 13, pp. 1467-1489

  3. Interleuquina-17A: posible mediador y diana terapéutica en la hipertensión

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 41, Núm. 3, pp. 244-257

  4. Intravenous iron therapy and the cardiovascular system: risks and benefits

    Clinical Kidney Journal, Vol. 14, Núm. 4, pp. 1067-1076

  5. Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapy

    Nefrologia, Vol. 41, Núm. 6, pp. 652-660

2020

  1. Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease

    Clinical Kidney Journal, Vol. 13, Núm. 6, pp. 1017-1024

  2. IL‐17A as a potential therapeutic target for patients on peritoneal dialysis

    Biomolecules, Vol. 10, Núm. 10, pp. 1-36

  3. TRAF3 Modulation: Novel Mechanism for the Anti-inflammatory Effects of the Vitamin D Receptor Agonist Paricalcitol in Renal Disease

    Journal of the American Society of Nephrology, Vol. 31, Núm. 9, pp. 2026-2042

2019

  1. Atherosclerosis in chronic kidney disease: More, less, or just different?

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 39, Núm. 10, pp. 1938-1966

  2. Erratum to: Lipid management in patients with chronic kidney disease (Nature Reviews Nephrology, (2018), 14, 12, (727-749), 10.1038/s41581-018-0072-9)

    Nature Reviews Nephrology

2018

  1. Association of FGF-2 concentrations with atheroma progression in chronic kidney disease patients

    Clinical Journal of the American Society of Nephrology, Vol. 13, Núm. 4, pp. 577-584

  2. Lipid management in patients with chronic kidney disease

    Nature Reviews Nephrology, Vol. 14, Núm. 12, pp. 727-749

2017

  1. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: The NEFRONA study

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 513-520

2015

  1. Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

    Nephrology Dialysis Transplantation, Vol. 30, Núm. 7, pp. 1176-1185

  2. Impaired Vitamin D signaling in endothelial cell leads to an enhanced leukocyte-endothelium interplay: Implications for atherosclerosis development

    PLoS ONE, Vol. 10, Núm. 8